Loading…
Loading…
Tender ID
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
Tender Value
Refer Docs
Closing Date
17 Apr 2025, 11:25 amClosed
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
Single Packet
Normal Tender
No
Not Applicable
Itemwise/Consigneewise
Lowest to Highest
CONSIGNEE
Not Applicable
60 days
Expenditure
General
33
6 conditions
1 The offered product by the firm must be included in their product list uploaded on Railway Board website. If any firm offers a product which is not available in the Railway Board approved product list, that offer will be liable to be rejected. If firms or offered product by firms are not in approved list of RB than it to be purchased from firms or product(make/brand) which are approved by PCMD for inclusion to purchase as per DPP.
The medicines and drugs are reserved to be purchased from firms registered with Railway Board and manufacturing unit of the offered product should be inspected and passed fit by Railway Board. If firms or offered product by firms are not in approved list of RB than it to be purchased from firms or product(make/brand) which are approved by PCMD for inclusion to purchase as per DPP. However, in case of medical stores other than medicines such as rubber goods, consumables, implants and appliance etc. not covered under the new drug policy guidelines issued by Railway Board, the purchaser reserve its right to purchase it from the firms registered with NWR Jaipur, who are either manufacturing, marketing or even distributing agency for the product offered. In such cases the inspection of manufacturing unit is not mandatory.
Railways shall purchase this item from Pharma CPSEs and their subsidiaries where the Govt. of India owns 51 percent share or above subject to their meeting good manufacturing practice norms as per Schedule M of drugs and cosmetic rules.
In case Pharma CPSEs and their subsidiaries fail to supply/quote for the medicines, the procuring entity would be at liberty to make purchase from other manufacturers. If the Pharma CPSEs or their subsidiaries fail to perform as per P.O., they would also be subject to payment of liquidated damages or any other penalty as per IRS conditions of contract.
The eligibility criteria stated/mentioned at Sr. No. 3 & 4, will only be applicable if the tendered items are available in the list of medicines reserved for procurement from Pharma CPSEs, which is in line with the guidelines issued by Railway Board regarding implementation of Pharmaceuticals Preferential Purchase policy over Indian Railways.
This is PAC item. Only OEM of tendered item or it's authorized agent are eligible to participate in this tender.
14 conditions
Please write/mention name & address of the marketing/importing agency with details of authorized distributor.
The firm will mention name(s) of specific stores of area where such drug is being sold in the open market. The zone will undertake random 5% check to establish that the product quoted by the firm is actually available in the store(s) mentioned by the firm. Further, if at the point of time of inspection such drug is not available in the Store (s) due sale of available stock, the retailer will be asked to provide a copy of purchase memo/supply order of the product from the firm.
The bidders are required to quote rates for one tablet/capsule.
The bidder confirms that rates and other financial terms quoted in relevant columns of financial bid will only be ruling terms for acceptance, and such terms quoted anywhere else should be ignored. (Denial of this condition not recommended).
Please enter the percentage of local content in the material being offered. Please enter 0 for fully imported items, and 100 for fully indigenous items. The definition and calculation of local content shall be in accordance with the Make in India policy as incorporated in the tender conditions.
Please enter the percentage of local content in the material being offered. Please enter 0 for fully imported items, and 100 for fully indigenous items. The definition and calculation of local content shall be in accordance with the Make in India policy as incorporated in the tender conditions.
By consignee after receipt.
1 location across Rajasthan · 1 Numbers total
INJ USTEKINUMAB 90 MG/1 ML
33255201A
33255201A
PAC - Indigenous
Goods
Jodhpur, Rajasthan
₹0
Exempted
17 Apr 2025
8 Apr 2025
1 item · 1 Numbers total
INJ USTEKINUMAB 90 MG/1 ML [ Warranty Period: 30 Months after the date of delivery ] ]
| Delivery Location | State | Quantity |
|---|---|---|
| CHIEF MEDICAL SUPDT. JODHPUR, NWR | Rajasthan | 1.00 Numbers |
| Total | 1 Numbers | |
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
details.html
HTML
nit.pdf
NIT
5344108.pdf
ATTACHMENT
5344099.pdf
ATTACHMENT
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .